{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:29:40Z","timestamp":1793651380979,"version":"4.5.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.toxrep.2026.102330","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:04:10Z","timestamp":1786806250000},"page":"102330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Toxicological and pharmacodynamic evaluation of Nixodine-S [(S)-6-Methylnicotine] relative to (S)-nicotine"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3787-8649","authenticated-orcid":false,"given":"Marissa L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Costigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Preston","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana E.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie J.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxrep.2026.102330_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1098-2299(199809)45:1<10::AID-DDR2>3.0.CO;2-G","article-title":"Structure\u2013activity relationships for nicotine analogs comparing competition for [3H]nicotine binding and psychotropic potency","volume":"45","author":"Wang","year":"1998","journal-title":"Drug. Dev. Res."},{"key":"10.1016\/j.toxrep.2026.102330_bib2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0223-5234(97)89850-9","article-title":"Pyrrolidine-modified and 6-substituted analogs of nicotine: a structure-affinity investigation","volume":"31","author":"Dukat","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.toxrep.2026.102330_bib3","series-title":"Report A 0500\/3006.01 acute toxicity with LD50 (effect: convulsions) in male mice, intravenous application","author":"Rylander","year":"1979"},{"key":"10.1016\/j.toxrep.2026.102330_bib4","author":"Rylander","year":"1982"},{"key":"10.1016\/j.toxrep.2026.102330_bib5","first-page":"3536","article-title":"Isolation of a nicotine binding site from rat brain by affinity chromatography","volume":"80","author":"Abood","year":"1983"},{"key":"10.1016\/j.toxrep.2026.102330_bib6","doi-asserted-by":"crossref","unstructured":"OECD. (2010). Test No. 129: Guidance Document on Using Cytotoxicity Tests to Estimate Starting Doses for Acute Oral Systematic Toxicity Tests. Retrieved from Paris: https:\/\/doi.org\/10.1787\/d77a7e39-en.","DOI":"10.1787\/d77a7e39-en"},{"key":"10.1016\/j.toxrep.2026.102330_bib7","unstructured":"OECD. (2023). Test No. 487: In Vitro Mammalian Cell Micronucleus Test (9789264264861). Retrieved from https:\/\/www.oecd-ilibrary.org\/content\/publication\/9789264264861-en."},{"key":"10.1016\/j.toxrep.2026.102330_bib8","unstructured":"OECD. (2020). Test No. 471: Bacterial Reverse Mutation Test (9789264071247). Retrieved from Paris: https:\/\/www.oecd-ilibrary.org\/content\/publication\/9789264071247-en."},{"key":"10.1016\/j.toxrep.2026.102330_bib9","unstructured":"International Organization for Standardization [ISO]. (2009). ISO 10993-5 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity. Retrieved from https:\/\/www.iso.org\/standard\/36406.html."},{"key":"10.1016\/j.toxrep.2026.102330_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1670883","article-title":"Nicotine and neuronal nicotinic acetylcholine receptors: unraveling the mechanisms of nicotine addiction","volume":"19","author":"Jiang","year":"2025","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102330_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/pharmrev.121.000299","article-title":"Neurobiological mechanisms of nicotine reward and aversion","volume":"74","author":"Wills","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxrep.2026.102330_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1427314","article-title":"The double-edged nature of nicotine: toxicities and therapeutic potentials","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxrep.2026.102330_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuropharm.2013.09.008","article-title":"Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability","volume":"76","author":"Fowler","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102330_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-013-3082-0","article-title":"Ventral tegmental area \u03b16\u03b22 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core","volume":"229","author":"Wickham","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.toxrep.2026.102330_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuropharm.2014.11.019","article-title":"The habenulo-interpeduncular pathway in nicotine aversion and withdrawal","volume":"96","author":"Antolin-Fontes","year":"2015","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102330_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.addbeh.2010.03.004","article-title":"Initial response to cigarettes predicts rate of progression to regular smoking: findings from an offspring-of-twins design","volume":"35","author":"Sartor","year":"2010","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102330_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1152\/physiolgenomics.00202.2003","article-title":"Mice lacking neuronal nicotinic acetylcholine receptor \u03b24-subunit and mice lacking both \u03b15- and \u03b24-subunits are highly resistant to nicotine-induced seizures","volume":"17","author":"Kedmi","year":"2004","journal-title":"Physiol. Genom."},{"issue":"1-2","key":"10.1016\/j.toxrep.2026.102330_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-328X(01)00309-6","article-title":"Absence of \u03b17-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures","volume":"98","author":"Franceschini","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.toxrep.2026.102330_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fphar.2017.00057","article-title":"Nicotine elicits convulsive seizures by activating amygdalar neurons","volume":"8","author":"Iha","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"30","key":"10.1016\/j.toxrep.2026.102330_bib20","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1523\/JNEUROSCI.0937-11.2011","article-title":"\u03b14\u03b22 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief","volume":"31","author":"McGranahan","year":"2011","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102330_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2011.06.001","article-title":"Role of \u03b16 nicotinic receptors in CNS dopaminergic function: relevance to Parkinson's disease and drug discovery","volume":"82","author":"Quik","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.toxrep.2026.102330_bib22","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/sj.npp.1301617","article-title":"\u03b16-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens","volume":"33","author":"Exley","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"28","key":"10.1016\/j.toxrep.2026.102330_bib23","doi-asserted-by":"crossref","first-page":"25331","DOI":"10.1074\/jbc.M111.221754","article-title":"Desensitization of \u03b17 nicotinic receptor is governed by coupling strength relative to gate tightness","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.toxrep.2026.102330_bib24","article-title":"Hidden complexity of \u03b17 nicotinic acetylcholine receptor gating and pharmacology","volume":"122","author":"Avstrikova","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:01:52Z","timestamp":1793649712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750026001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S2214750026001320"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102330","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicological and pharmacodynamic evaluation of Nixodine-S [(S)-6-Methylnicotine] relative to (S)-nicotine","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102330"}}